Stay current on changes and developments in corporate law with a wide variety of resources and tools.
By Eric Topor
The DOJ recently provided health-care fraud attorneys with a detailed view of how the agency evaluates corporate compliance programs in fraud investigations, providing much-needed practical guidance for the industry.
The guidance, titled Evaluation of Corporate Compliance Programs, was published Feb. 8 by the Department of Justice’s Criminal Division. It consists of a series of questions federal prosecutors “may ask in making an individualized determination” of how to judge a corporation’s compliance efforts in a fraud investigation.
Michael W. Peregrine, a partner with McDermott Will & Emery in Chicago, told Bloomberg BNA Feb. 22 that compliance attorneys have been waiting for this type of practical guidance from the DOJ. Peregrine, who focuses his practice on corporate governance, said the document was “conduct-focused,” and provides corporate boards and general counsels with “practical, nuts and bolts” guidance. “It’s the most detailed thing we’ve ever had” from the DOJ, Peregrine said.
Melissa L. Jampol, with Epstein Becker & Green, saw a connection between the timing of the guidance and the confirmation of Jeff Sessions as attorney general on Feb. 8. Jampol, a New York member in the firm’s life sciences practice, told Bloomberg BNA Feb. 22 the guidance’s release signals the DOJ’s intention to continue its current course of pursuing health-care fraud, especially in light of the monetary return generated from health-care fraud enforcement and the growing share of the economy devoted to health care.
The effectiveness of an existing corporate compliance program is one of the factors that DOJ attorneys use in deciding whether to bring fraud charges against a corporation accused of fraud, pursuing other types of corrective actions or deciding against bringing charges at all. The guidance isn’t specific to any industry, and draws extensively from the agency’s Foreign Corrupt Practices Act Guide, released in 2012.
Although the document explicitly applies to criminal investigations, Jampol said the questions it asks of compliance programs “could also apply to civil investigations, and civil negotiations” with the DOJ.
Jampol added that corporate attention to DOJ compliance concerns can pay dividends “in terms of the resolution you get with the DOJ.” Cooperation “is definitely rewarded” by the DOJ, Jampol said, and this guidance “provides a roadmap for discussions with the DOJ.”
Peregrine said the guidance was “important reading for general counsels, compliance officers and audit compliance committees,” and provides a standard for a corporation to compare to its own compliance program and efforts.
The guidance covers a broad range of topics, from internal investigations to program design to merger and acquisition concerns. Peregrine noted that not all of the guidance is applicable to all corporations or industries, and it’s up to a corporation’s general counsel and audit compliance committee to interpret the guidance and determine which portions are relevant to its own situation.
Jampol said the DOJ wants companies to undertake “vigorous internal investigations,” the subject of the first section of the guidance (Analysis and Remediation of Underlying Misconduct), and shows an “emphasis on proactive, not reactive” compliance protocols. “You need to have a game plan in advance” on how to handle a problem, Jampol said, and be able to respond to agency search warrants and civil investigative demands, and to put necessary litigation holds on electronic records in place.
The guidance also outlines agency concerns for “Confidential Reporting and Investigation,” which could be applicable to how a corporation responds to whistle-blowers who are ringing internal alarm bells about questionable corporate conduct. Jampol said there has been a trend of compliance officers filing whistle-blower actions under the False Claims Act after their concerns were spurned.
To contact the reporter on this story: Eric Topor in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Peyton Sturges at email@example.com
The guidance is at http://src.bna.com/mo7.
Copyright © 2017 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)